Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Biotechnol ; 32(12): 1256-61, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25402614

ABSTRACT

RNA interference (RNAi) has great potential to treat human disease. However, in vivo delivery of short interfering RNAs (siRNAs), which are negatively charged double-stranded RNA macromolecules, remains a major hurdle. Current siRNA delivery has begun to move away from large lipid and synthetic nanoparticles to more defined molecular conjugates. Here we address this issue by synthesis of short interfering ribonucleic neutrals (siRNNs) whose phosphate backbone contains neutral phosphotriester groups, allowing for delivery into cells. Once inside cells, siRNNs are converted by cytoplasmic thioesterases into native, charged phosphodiester-backbone siRNAs, which induce robust RNAi responses. siRNNs have favorable drug-like properties, including high synthetic yields, serum stability and absence of innate immune responses. Unlike siRNAs, siRNNs avidly bind serum albumin to positively influence pharmacokinetic properties. Systemic delivery of siRNNs conjugated to a hepatocyte-specific targeting domain induced extended dose-dependent in vivo RNAi responses in mice. We believe that siRNNs represent a technology that will open new avenues for development of RNAi therapeutics.


Subject(s)
Drug Delivery Systems , Prodrugs/therapeutic use , RNA, Small Interfering/therapeutic use , Animals , Humans , Mice , Nanoparticles/chemistry , Nanoparticles/therapeutic use , Prodrugs/chemistry , RNA, Small Interfering/chemistry , RNA, Small Interfering/genetics , Serum Albumin/chemistry
2.
Curr Pharm Des ; 19(16): 2943-7, 2013.
Article in English | MEDLINE | ID: mdl-23140460

ABSTRACT

siRNA-induced RNA Interference (RNAi) responses have great potential to treat human disease; however, siRNAs are highly charged macromolecules with no ability to enter cells and require a delivery agent. Peptide Transduction Domains (PTDs), also called Cell Penetrating Peptides (CPPs), are delivery peptides with the potential to deliver macromolecular peptides, proteins and siRNAs into cells. Here we discuss the multitude of ways that PTDs/CPPs have been utilized to deliver siRNAs from direct conjugates to complex nanoparticles. PTD/CPP-mediated siRNA delivery has come a long way and has great potential to address the siRNA delivery problem.


Subject(s)
Cell-Penetrating Peptides/chemistry , RNA Interference , RNA, Small Interfering/administration & dosage , Animals , Cell-Penetrating Peptides/metabolism , Gene Transfer Techniques , Humans , Macromolecular Substances/administration & dosage , Nanoparticles , Peptides/administration & dosage , Proteins/administration & dosage
3.
PLoS Genet ; 4(6): e1000102, 2008 Jun 20.
Article in English | MEDLINE | ID: mdl-18566664

ABSTRACT

The larval salivary gland of Drosophila melanogaster synthesizes and secretes glue glycoproteins that cement developing animals to a solid surface during metamorphosis. The steroid hormone 20-hydroxyecdysone (20E) is an essential signaling molecule that modulates most of the physiological functions of the larval gland. At the end of larval development, it is known that 20E--signaling through a nuclear receptor heterodimer consisting of EcR and USP--induces the early and late puffing cascade of the polytene chromosomes and causes the exocytosis of stored glue granules into the lumen of the gland. It has also been reported that an earlier pulse of hormone induces the temporally and spatially specific transcriptional activation of the glue genes; however, the receptor responsible for triggering this response has not been characterized. Here we show that the coordinated expression of the glue genes midway through the third instar is mediated by 20E acting to induce genes of the Broad Complex (BRC) through a receptor that is not an EcR/USP heterodimer. This result is novel because it demonstrates for the first time that at least some 20E-mediated, mid-larval, developmental responses are controlled by an uncharacterized receptor that does not contain an RXR-like component.


Subject(s)
Drosophila Proteins/physiology , Drosophila melanogaster/physiology , Ecdysterone/physiology , Metamorphosis, Biological/physiology , Receptors, Steroid/physiology , Animals , Animals, Genetically Modified , DNA-Binding Proteins/physiology , Dimerization , Drosophila Proteins/genetics , Drosophila melanogaster/genetics , Drosophila melanogaster/growth & development , Gene Expression Regulation, Developmental/physiology , Glue Proteins, Drosophila/genetics , Glue Proteins, Drosophila/metabolism , Larva/genetics , Larva/growth & development , Metamorphosis, Biological/genetics , Transcription Factors/genetics , Transcription Factors/physiology , Transgenes/physiology
4.
Proc Natl Acad Sci U S A ; 101(6): 1764-8, 2004 Feb 10.
Article in English | MEDLINE | ID: mdl-14752200

ABSTRACT

A role for Notch in the elaboration of existing neural processes is emerging that is distinct from the increasingly well understood function of this gene in binary cell-fate decisions. Several research groups, by using a variety of organisms, have shown that Notch is important in the development of neural ultrastructure. Simultaneously, Presenilin (Psn) was identified both as a key mediator of Notch signaling and as a site of genetic lesions that cause early-onset Alzheimer's disease. Here we demonstrate that Notch loss of function produces memory deficits in Drosophila melanogaster. The effects are specific to long-term memory, which is thought to depend on ultrastructural remodeling. We propose that Notch plays an important role in the neural plasticity underlying consolidated memory.


Subject(s)
Drosophila/physiology , Membrane Proteins/physiology , Memory/physiology , Animals , Conditioning, Classical , Drosophila/genetics , Drosophila Proteins , Membrane Proteins/genetics , Mutation , RNA Interference/physiology , Receptors, Notch
SELECTION OF CITATIONS
SEARCH DETAIL
...